AllianceBernstein’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153K Hold
44,760
﹤0.01% 3106
2025
Q4
$153K Hold
44,760
﹤0.01% 3114
2025
Q3
$304K Hold
44,760
﹤0.01% 2936
2025
Q2
$610K Buy
44,760
+27,300
+156% +$258K ﹤0.01% 2526
2025
Q1
$95K Hold
17,460
﹤0.01% 3074
2024
Q4
$86.4K Hold
17,460
﹤0.01% 3138
2024
Q3
$91.5K Hold
17,460
﹤0.01% 3142
2024
Q2
$120K Buy
+17,460
New +$160K ﹤0.01% 3101
2021
Q3
Sell
-53,266
Closed -$627K 3318
2021
Q2
$627K Buy
+53,266
New +$613K ﹤0.01% 2723

Other funds holding LFMD

AllianceBernstein's LFMD Position: Q1 2026 in Review

AllianceBernstein held its LifeMD (LFMD) position steady in Q1 2026 at 44,760 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

AllianceBernstein first reported a position in LFMD in Q2 2021 and has held it in 9 quarters since. The position peaked at $627K in Q2 2021. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • AllianceBernstein held 44,760 shares of LifeMD worth $153K as of Q1 2026.
  • AllianceBernstein left its LifeMD share count unchanged in Q1 2026.
  • LifeMD made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3106 holding.
  • AllianceBernstein first reported a position in LifeMD in Q2 2021 and has held it in 9 quarters since.
  • AllianceBernstein's LifeMD position peaked at $627K in Q2 2021.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.